Literature DB >> 24461515

Hypnic headache: a descriptive study of 25 new cases in Brazil.

Raimundo Pereira Silva-Néto1, Kelson James Almeida2.   

Abstract

Our aim was to show the clinical characteristics of 25 patients with hypnic headache. We reviewed the medical records of 11,360 patients who complained of headache and selected those with hypnic headache, according to the criteria of the International Classification of Headache Disorders-2. Twenty-five patients (20 women and 5 men) were diagnosed with hypnic headache. The average age at the headache onset was 65.6 ± 11.4 years (95% CI 61.1-70.1), ranging from 51 to 89 years. The diagnosis of hypnic headache was made 3.0 ± 2.7 years (95% CI 1.9-4.0) after the headache started. Fourteen patients (56.0%) were awakened between 4:00 and 6:00 a.m. The headache lasted for more than 2h in 16 (64.0%) patients. The headache was bilaterally localized (16/25; 64.0%), had a dull character (18/25; 72.0%) and a moderate intensity (17/25; 68.0%). The frequency was greater than 15 days per month (14/25; 56.0%). Associated symptoms were reported by 7 patients: nausea (71.4%) and phonophobia (28.6%). There was successful treatment with lithium carbonate in 16/22 (72.7%) of the patients. Hypnic headache occurs exclusively during sleep in the elderly and especially in women. Lithium is an effective drug for its treatment.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical characteristics; Diagnostic criteria; Hypnic headache; Lithium carbonate; Nocturnal headache; Primary headache

Mesh:

Year:  2014        PMID: 24461515     DOI: 10.1016/j.jns.2013.12.042

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  1 in total

1.  The prevalence of hypnic headache in Iceland.

Authors:  Jon H Eliasson; Ann I Scher; Dawn C Buse; Gretchen Tietjen; Richard B Lipton; Lenore J Launer; Unnur A Valdimarsdottir; Larus S Gudmundsson
Journal:  Cephalalgia       Date:  2020-03-09       Impact factor: 6.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.